Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus: A randomized, controlled trial

Annals of Internal Medicine

Volumn 128, Issue 12 PART 1, 1998, Pages 982-988

  Ravid, Mordchai ^a   Brosh, David ^a   Levi, Zohar ^a,b   Bar Dayan, Yosefa ^a,b   Ravid, Dorit ^a,b   Rachmani, Rita ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CODING; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0032525867     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-128-12_part_1-199806150-00004     Document Type: Article

References (33)

1. Miles DW, Mogensen CE, Gundersen HJ. Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest. 1970;26:5-11
2. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984;311:89-93.
3. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H, Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet, 1982:1:1430-2.
4. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328:1676-85.
5. Mogensen CE, Damsgaard EM, Froland A, Nielsen S, De Fine Olivarius N, Schmits A. Microalbuminuria in non-insulin-dependent diabetes. Clin Nephrol. 1992;38(Suppl 1):S28-39.
6. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care. 1993;16:996-1003.
7. Mattok MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 1992;41:736-41.
8. Dinneen SF, Gerstein H. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med. 1997;157:1413-8.
9. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy. BMJ. 1992;304:339-43.
10. Parving HH, Rossing P, Hommel E, Smidt UM. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience. Am J Kidney Dis. 1995;26:99-107.
11. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993;329:1456-62.
12. Bakris GL, Barnhill BW, Sadler R. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int. 1992;41: 912-9.
13. Mathiesen ER, Hommel E, Giese J, Parving HH. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ. 1991;303:81-7.
14. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J. Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ. 1988;297:1092-5.
15. Ravid M, Lang R, Rachmani R, Lishner M. Long term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med. 1996;156:286-9.
16. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group. Lancet. 1997;349:1787-92.
17. World Health Organization expert committee on diabetes mellitus: second report. Geneva: World Health Organization; 1980. Technical report series no. 646.
18. Shott S. Statistics for Health Professionals. Philadelphia: WB Saunders; 1990: 57-60.
19. Sathianathan P, Rege VP, Barron JL. Immunoturbidimetric determination of urinary albumin with a centrifugal analyzer. Clin Chem. 1986;32(1 Pt 1):202.
20. Bartels H, Bohmer M, Heierli C. [Serum creatinine determination without protein precipitation.] Clin Chim Acta. 1972;37:193-7.
21. Motulsky H. Intuitive Biostatistics. New York: Oxford Univ Pr; 1995:198-200.
22. Lebovitz HE, Wiegmann TB, Cnaan A, Shahinfar S, Sica D, Broadstone V, et al. Renal protective effect of enalapril in hypertensive NIDDM: role of baseline albuminuria. Kidney Int Suppl. 1994;45:S150-5.
23. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med. 1993;118:577-81.
24. Rossing P, Hommel E, Smidt UM, Parving HH. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertension treatment. Diabetologia. 1994;37:511-6.
25. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986;77:1925-30.
26. Kasiske BL, Kalil RSN, Ma JZ, Liav M, Keane WF. Effect of antihypertensive therapy on the kidneys in patients with diabetes: a meta-regression analysis. Ann Intern Med. 1993;118:129-38.
27. Ravid M, Rachmani R. Cholesterol as a predictor of progression in diabetic renal disease. Contrib Nephrol. 1997:120:39-47.
28. Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes A 10-year following study of 503 patients. Diabet Med. 1988;5:126-34.
29. Derby L, Warram JH, Laffel LM, Krolewski AS. Elevated blood pressure predicts the development of persistent albuminuria in the presence of poor glycemic control, in patients with type I diabetes. Diabetes Metab. 1989;15(5 Pt 2):320-6.
30. Konen J, Shihabi Z, Newman J. The association of non-insulin-dependent diabetes mellitus and hypertension with urinary excretion of albumin and transferrin. Am J Kidney Dis. 1993;22:791-7.
31. Koren W, Koldanov R, Pronin VS, Postnov IY, Peleg E, Rosenthal T, et al. Amiloride-sensitive Na+/H+ exchange in erythrocytes of patients with NIDDM: a prospective study. Diabetologia. 1997;40:302-6.
32. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Is blood pressure a predictor of the incidence of progression of diabetic retinopathy? Arch Intern Med. 1989;149:2427-32.
33. Janka HU, Warram JH, Rand U, Krolewski AS. Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes. 1989;38: 460-4.